Prevalence of rifampicin-resistant pediatric tuberculosis by cartridge-based nucleic acid amplification test at the intermediate reference laboratory under revised national tuberculosis control program India: A multidimensional approach
Background: Tuberculosis (TB) still remains the major public health threat in India. Early diagnosis, so as to initiate early treatment is a priority as any delay, may complicate the prognosis further leading to the failure of an effective control. India accounts for 6% incidence of pediatric TB cas...
Main Authors: | Prasanta Kumar Das, Somtirtha B Ganguly, Bodhisatya Mandal, Abhijit Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Biomedical and Biotechnology Research Journal |
Subjects: | |
Online Access: | http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2018;volume=2;issue=4;spage=300;epage=305;aulast=Das |
Similar Items
-
Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
by: Kanchan Ajbani, et al.
Published: (2019-01-01) -
Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01) -
Detection of Rifampicin Resistance among Patients with Tuberculosis using GeneXpert MTB/RIF Assay: A Retrospective Study
by: Gayathridevi Durairaj, et al.
Published: (2020-09-01) -
Impact of cartridge-based nucleic acid amplification test (CBNAAT) introduction on the detection of pulmonary and extra-pulmonary tuberculosis in Bhubaneswar, Odisha
by: Himadri Bhusan Bal, et al.
Published: (2023-01-01) -
Comparison of Xpert MTB RIF (G4) With Xpert MTB (Ultra) in Diagnosis of Mycobacterium Tuberculosis in Clinical Samples
by: Ann Mathew, et al.
Published: (2024-09-01)